BOW015 (Infliximab-EPIRUS) and Infliximab in Patients With Active Rheumatoid Arthritis: The UNIFORM Study
Clinical trial NCT02683564 · UNKNOWN
Trial details
- NCT number
- NCT02683564
- Sponsor
- Epirus Biopharmaceuticals (Switzerland) GmbH
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-02-01
- Primary completion
- 2017-07-01
- Enrollment
- 548
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.